← FDA Drug Approvals (Drugs@FDA)

ATOVAQUONE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: BIONPHARMA · Approved 2021-03-30

Drug application

FDA Application #
ANDA212918
Application type
Abbreviated New Drug Application (Generic)
Brand name
ATOVAQUONE
Generic name
ATOVAQUONE
Active ingredients
ATOVAQUONE
Dosage form
SUSPENSION
Route
ORAL
Marketing status
Prescription
Sponsor
BIONPHARMA
Manufacturer
Bionpharma Inc.
First approval
2021-03-30

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown